Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription 20.01.2025 5 AIDS 2 AIDS Res Hum Retroviruses 1 Am J Hematol 1 Antimicrob Agents Chemother 1 BMJ 1 Br J Haematol 2 Clin Infect Dis 3 HIV Med 11 J Acquir Immune Defic Syndr 1 J Infect Dis 1 J Med Virol 4 J Virol 1 Lancet 1 Pediatr Infect Dis J 1 PLoS Med 7 PLoS One 1 PLoS Pathog

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. BRANTON WG, Zhang N, Cohen EA, Brew BJ, et al
   Brain RNA profiling highlights multiple disease pathways in persons with HAND: uncovering determinants of biotype diversity.
   AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004116.
   PubMed         Abstract available
   
   
2. PANG X, Ma J, He Q, Tang K, et al
   Analysis of HIV transmission characteristics and intervention effects in Guangxi based on molecular networks.
   AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004123.
   PubMed         Abstract available
   
   
3. PATEL VV, Andrade EA, Zimba R, Mirzayi C, et al
   Preferences for HIV PrEP care among gay, bisexual, and other men who have sex with men: a large discrete choice experiment.
   AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004124.
   PubMed         Abstract available
   
   
4. LUCKETT R, Ramogola-Masire D, Zash R, Sears E, et al
   Cervical dysplasia in women with HIV in the modern treat-all era: Elevated risk remains despite long-term ART and normal CD4 count.
   AIDS. 2025 Jan 13. doi: 10.1097/QAD.0000000000004120.
   PubMed         Abstract available
   
   
5. DOLLFUS C, Chenadec JL, Reliquet V, Alby-Laurent F, et al
   Outcomes and challenges in adolescents living with HIV in France: a nationwide cohort study over 35 years (1985-2020).
   AIDS. 2025 Jan 13. doi: 10.1097/QAD.0000000000004121.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

6. WANG X, Zhu B, Li H, Han J, et al
   Identification of a Novel HIV-1 Second-Generation Circulating Recombinant Form (CRF117_0107) in China.
   AIDS Res Hum Retroviruses. 2025 Jan 17. doi: 10.1089/aid.2024.0106.
   PubMed         Abstract available
   
   
7. CAO B, Liu M, Song S, Guo M, et al
   HIV-1 DNA Genotypic Drug Resistance Testing Guides Antiretroviral Therapy in Patients with Low-Level Viremia.
   AIDS Res Hum Retroviruses. 2025 Jan 15. doi: 10.1089/aid.2024.0088.
   PubMed         Abstract available
   
   

   
   Am J Hematol

8. LURAIN K, Ramaswami R, Oksenhendler E, Boutboul D, et al
   Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion Lymphoma.
   Am J Hematol. 2025 Jan 15. doi: 10.1002/ajh.27580.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

9. FILLGROVE KL, Matthews RP, Lu B, Liang Y, et al
   Nonclinical and clinical characterization of the absorption, metabolism, and excretion of islatravir.
   Antimicrob Agents Chemother. 2025 Jan 14:e0103024. doi: 10.1128/aac.01030.
   PubMed         Abstract available
   
   

   
   BMJ

10. SHEATHER J, Phillips M
    Ethics and corridor care: a contradiction in terms?
    BMJ. 2025;388:r91.
    PubMed        
    
    

    
    Br J Haematol

11. CHIRIAC R
    Concomitant HIV-associated plasmablastic lymphoma and visceral leishmaniasis at initial presentation.
    Br J Haematol. 2025 Jan 12. doi: 10.1111/bjh.19971.
    PubMed        
    
    

    
    Clin Infect Dis

12. WONDMENEH S, McDonald R, Quilter LAS, Workowski K, et al
    Reported Neurologic Manifestations Among Persons with Syphilis by Stage of Infection-12 States, 2019 -2022.
    Clin Infect Dis. 2025 Jan 17:ciaf015. doi: 10.1093.
    PubMed         Abstract available
    
    
13. BARRE T, Ramier C, Wittkop L, Sogni P, et al
    Low CD4 cell count is associated with post-hepatitis C virus cure mortality in people living with HIV (ANRS CO13 HEPAVIH cohort).
    Clin Infect Dis. 2025 Jan 15:ciaf016. doi: 10.1093.
    PubMed        
    
    

    
    HIV Med

14. MCGARRITY MW, MacPherson P, Li A, Naccarato M, et al
    Intracellular tenofovir-diphosphate concentrations in HIV pre-exposure prophylaxis users who underwent bariatric surgery.
    HIV Med. 2025 Jan 15. doi: 10.1111/hiv.13759.
    PubMed         Abstract available
    
    
15. MKHIZE N, Garrido J, Cole-Haley S, Diallo DD, et al
    Breaking down global barriers: A multinational and multi-community approach to combat stigma and enhance mental wellbeing in people with HIV.
    HIV Med. 2025 Jan 16. doi: 10.1111/hiv.13763.
    PubMed         Abstract available
    
    
16. NELSON M, Bracchi M, Hunter E, Ong E, et al
    British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non-tuberculous mycobacteria 2024.
    HIV Med. 2024;25 Suppl 4:3-25.
    PubMed        
    
    

    
    J Acquir Immune Defic Syndr

17. CALZA L, Colangeli V, Giglia M, Rigamonti C, et al
    EFFICACY AND SAFETY OF DOLUTEGRAVIR/LAMIVUDINE IN ANTIRETROVIRAL THERAPY-NAIVE PEOPLE LIVING WITH HIV-1 AND WITH HIGH-LEVEL VIREMIA.
    J Acquir Immune Defic Syndr. 2025 Jan 14. doi: 10.1097/QAI.0000000000003600.
    PubMed         Abstract available
    
    
18. CARNEIRO PB, Radix AE, Golub S, Grosskopf N, et al
    PrEP Use in a US National Sample of Trans Men and Other Transmasculine People Who Have Sex With Men: A Longitudinal Analysis.
    J Acquir Immune Defic Syndr. 2024;97:357-363.
    PubMed         Abstract available
    
    
19. HO K, Hoesley C, Anderson PL, Fernandez-Romero JA, et al
    Phase I Dose Volume Escalation of Rectally Administered PC-1005 to Assess Safety, Pharmacokinetics, and Antiviral Pharmacodynamics as a Multipurpose Prevention Technology (MTN-037).
    J Acquir Immune Defic Syndr. 2024;97:379-386.
    PubMed         Abstract available
    
    
20. EGER WH, Shaw LC, Biello KB, Lopez C, et al
    HIV pre-exposure prophylaxis prescription initiation and maintenance among homeless-experienced people who use drugs.
    J Acquir Immune Defic Syndr. 2024 Nov 21. doi: 10.1097/QAI.0000000000003568.
    PubMed         Abstract available
    
    
21. DUNN DT, McCabe L, Ward D, Phillips AN, et al
    Assessing whether providing regular, free HIV self-testing kits reduces the time to HIV diagnosis: an internet-based, randomised controlled trial in men who have sex with men.
    J Acquir Immune Defic Syndr. 2024 Nov 22. doi: 10.1097/QAI.0000000000003564.
    PubMed         Abstract available
    
    
22. PEREZ-BRUMER A, Apedaile D, Leon-Morris F, Huerta L, et al
    Migration is associated with increased HIV vulnerability among young transgender women in Lima, Peru.
    J Acquir Immune Defic Syndr. 2024 Nov 15. doi: 10.1097/QAI.0000000000003560.
    PubMed         Abstract available
    
    
23. SMITH MK, Luo D, Meng S, Fei Y, et al
    An Incognito Standardized Patient Approach for Measuring and Reducing Intersectional Healthcare Stigma: A Pilot Cluster Randomized Control Trial.
    J Acquir Immune Defic Syndr. 2024 Nov 21. doi: 10.1097/QAI.0000000000003565.
    PubMed         Abstract available
    
    
24. MANAVALAN P, Gadkowski LB, Sachdeva A, Guha S, et al
    Acceptability of multi-level sexual health interventions and sexually transmitted infection screening and testing among persons with HIV across three clinical sites in Florida.
    J Acquir Immune Defic Syndr. 2024 Nov 20. doi: 10.1097/QAI.0000000000003569.
    PubMed         Abstract available
    
    
25. DOS SANTOS FC, Garofalo R, Kuhns L, Scherr T, et al
    Evaluating the Effectiveness of a Mobile Health Intervention on Enhancing HIV Knowledge in Sexual and Gender Minority Men.
    J Acquir Immune Defic Syndr. 2024 Nov 19. doi: 10.1097/QAI.0000000000003562.
    PubMed         Abstract available
    
    
26. POWIS KM, Pinilla M, McMorrow F, Stek A, et al
    Pharmacokinetics and safety of bictegravir in pregnant and postpartum persons with HIV and their infants.
    J Acquir Immune Defic Syndr. 2024 Nov 21. doi: 10.1097/QAI.0000000000003571.
    PubMed         Abstract available
    
    
27. DEVANATHAN AS, Poliseno AJ, White NR, Schauer AP, et al
    A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation.
    J Acquir Immune Defic Syndr. 2024 Nov 21. doi: 10.1097/QAI.0000000000003570.
    PubMed         Abstract available
    
    

    
    J Infect Dis

28. ELLIS RJ, Vaida F, Hu K, Dube M, et al
    Effects of Tesamorelin on Neurocognitive Impairment in Abdominally Obese Persons with HIV.
    J Infect Dis. 2025 Jan 15:jiaf012. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

29. ZANET E, Taborelli M, Tirelli U, Diez-Martin J, et al
    Long-Term Clinical Outcomes After Autologous Hematopoietic Stem Cell Transplantation in 49 Individuals Living With HIV (PLWH) and Affected by High-Risk or Relapsed Lymphoma: A European Experience of Continued Relevance for PLWH.
    J Med Virol. 2025;97:e70165.
    PubMed         Abstract available
    
    

    
    J Virol

30. COHEN P, Lambson BE, Mkhize NN, Moodley C, et al
    Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance.
    J Virol. 2025 Jan 16:e0173024. doi: 10.1128/jvi.01730.
    PubMed         Abstract available
    
    
31. LICHON DM, LoMascolo NJ, Mounce BC, Campbell EM, et al
    Microtubule acetylation is not required for HIV-1 infection or TRIM69-mediated restriction of HIV-1 infection.
    J Virol. 2025 Jan 13:e0102624. doi: 10.1128/jvi.01026.
    PubMed         Abstract available
    
    
32. FAYYAZ S, Lotke R, Haussmann I, Petersen M, et al
    Reactivation of latent HIV-1 by the glucocorticoid receptor modulator AZD9567.
    J Virol. 2025 Jan 16:e0188624. doi: 10.1128/jvi.01886.
    PubMed         Abstract available
    
    
33. ARA A, Love RP, Follack TB, Ahmed KA, et al
    Erratum for Ara et al., "Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G".
    J Virol. 2025 Jan 16:e0220424. doi: 10.1128/jvi.02204.
    PubMed        
    
    

    
    Lancet

34. KAMAL-YANNI M, Gangte L, Kittitrakul C, Meyer S, et al
    Is MSF changing course on access to medicines?
    Lancet. 2025;405:124-125.
    PubMed        
    
    

    
    Pediatr Infect Dis J

35. MAGDALENO AM, Friedrich L, Ramos MA, Corso AL, et al
    Prevalence of Anti-HIV Antibodies at 12 Months of Age in Infants Exposed to HIV.
    Pediatr Infect Dis J. 2025 Jan 17. doi: 10.1097/INF.0000000000004732.
    PubMed         Abstract available
    
    

    
    PLoS Med

36. KIM S, Can MH, Agizew TB, Auld AF, et al
    Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis.
    PLoS Med. 2025;22:e1004502.
    PubMed         Abstract available
    
    

    
    PLoS One

37. FAROOQ FB, Sultana S, Alqahtani NA, Imran M, et al
    Optimization of HIV drugs through MCDM technique Analytic Hierarchy Process(AHP).
    PLoS One. 2025;20:e0316617.
    PubMed         Abstract available
    
    
38. PATIL A, Vidhate P, Patil S, Rao A, et al
    Looking back into the Hepatitis C Virus epidemic dynamics from Unnao, India through phylogenetic approach.
    PLoS One. 2025;20:e0317705.
    PubMed         Abstract available
    
    
39. JANEK SE, Matos LA, Hatoum S, Mulawa MI, et al
    Racism, homophobia, and the sexual health of young Black men who have sex with men in the United States: A systematic review.
    PLoS One. 2025;20:e0316532.
    PubMed         Abstract available
    
    
40. KYOMUGISHA-NUWAGABA C, King R, Baryamutuma R, Muhumuza S, et al
    A qualitative study to understand the facilitators of and barriers to retention in care to the national PMTCT Option B+ programme in Uganda.
    PLoS One. 2025;20:e0314885.
    PubMed         Abstract available
    
    
41. SISODIA S, Hammond Z, Leonardi-Bee J, Hanlon C, et al
    Sexual and reproductive health needs of women with severe mental illness in low- and middle-income countries: A scoping review.
    PLoS One. 2025;20:e0311554.
    PubMed         Abstract available
    
    
42. FRIEDLAND BA, Gundacker H, Achilles SL, Chen BA, et al
    Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development.
    PLoS One. 2025;20:e0312957.
    PubMed         Abstract available
    
    
43. MUSYOKI VM, Mureithi M, Heikinheimo A, Maleche-Obimbo E, et al
    The impact of tuberculosis-induced hyperglycemia on pulmonary microbiota and airway mucus secretion in individuals not previously diabetic: A systematic review and meta-analysis protocol.
    PLoS One. 2025;20:e0316810.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

44. ROHLFES N, Radhakrishnan R, Singh PK, Bedwell GJ, et al
    The nuclear localization signal of CPSF6 governs post-nuclear import steps of HIV-1 infection.
    PLoS Pathog. 2025;21:e1012354.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.